Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients

​New research to be presented at next week's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) highlights the risk of new immune-evasive SARS-CoV-2 variants emerging in immunocompromised patients.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Amsterdam ,Noord Holland ,Netherlands ,Magda Vergouwe ,Global Congress ,Escmid Global Congress ,University Of Amsterdam ,Amsterdam University Medical Centerin ,Centre For Experimental ,Amsterdam University Medical Center ,Molecular Medicine ,Amsterdam University Medical Centerin February ,Sars ,Ars Cov 2 ,Ntibody ,Fell ,Iagnostic ,Revolution ,Enomic ,Hospital ,Medicine ,Micron ,Public Health ,Research ,Otrovimab ,Virus ,